Diabetic Neuropathy clinical trials

Explore recruiting diabetic neuropathy clinical trials.

Recruiting diabetic neuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Neuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

i-Care; Quantitative-imaging in cardiac transthyretin amyloidosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

HELIOS-A: A Phase 3 Global, Randomized, Open-label Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

Netherlands, Belgium, Cyprus, Spain, Portugal, Bulgaria +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Portugal, Sweden, Cyprus, Germany, France, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy: a double-blind, multicenter, placebo-controlled, international phase II clinical trial

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

TRITON-PN: A Phase 3, Global, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (hATTR-PN)

France, Italy, Greece, Spain, Sweden, Ireland +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Diabetic Neuropathy trials by city

Diabetic Neuropathy in Toronto Diabetic Neuropathy in Vancouver Diabetic Neuropathy in Montreal Diabetic Neuropathy in Calgary Diabetic Neuropathy in Edmonton Diabetic Neuropathy in Ottawa Diabetic Neuropathy in Winnipeg Diabetic Neuropathy in Quebec City Diabetic Neuropathy in Hamilton Diabetic Neuropathy in Kitchener Diabetic Neuropathy in London Diabetic Neuropathy in Halifax Diabetic Neuropathy in New York Diabetic Neuropathy in Los Angeles Diabetic Neuropathy in Chicago Diabetic Neuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease